Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Opt Express ; 12(8): 4689-4699, 2021 Aug 01.
Article in English | MEDLINE | ID: mdl-34513218

ABSTRACT

Glass micropipette electrodes are commonly used to provide high resolution recordings of neurons. Although it is the gold standard for single cell recordings, it is highly dependent on the skill of the electrophysiologist. Here, we demonstrate a method of guiding micropipette electrodes to neurons by collecting fluorescence at the aperture, using an intra-electrode tapered optical fiber. The use of a tapered fiber for excitation and collection of fluorescence at the micropipette tip couples the feedback mechanism directly to the distance between the target and electrode. In this study, intra-electrode tapered optical fibers provide a targeted robotic approach to labeled neurons that is independent of microscopy.

2.
J Vis Exp ; (155)2020 01 17.
Article in English | MEDLINE | ID: mdl-32009643

ABSTRACT

Many studies suggest that the enumeration of circulating tumor cells (CTCs) may show promise as a prognostic tool for ovarian cancer. Current strategies for the detection of CTCs include flow cytometry, microfluidic devices, and real-time polymerase chain reaction (RT-PCR). Despite recent advances, methods for the detection of early ovarian cancer metastasis still lack the sensitivity and specificity required for clinical translation. Here, a novel method is presented for the detection of ovarian circulating tumor cells by photoacoustic flow cytometry (PAFC) utilizing a custom three dimensional (3D) printed system, including a flow chamber and syringe pump. This method utilizes folic acid-capped copper sulfide nanoparticles (FA-CuS NPs) to target SKOV-3 ovarian cancer cells by PAFC. This work demonstrates the affinity of these contrast agents for ovarian cancer cells. The results show NP characterization, PAFC detection, and NP uptake by fluorescence microscopy, thus demonstrating the potential of this novel system to detect ovarian CTCs at physiologically relevant concentrations.


Subject(s)
Flow Cytometry , Ovarian Neoplasms/diagnosis , Photoacoustic Techniques , Cell Count , Cell Line, Tumor , Copper/chemistry , Female , Folic Acid/chemistry , Humans , Image Processing, Computer-Assisted , Microscopy, Fluorescence , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Neoplastic Cells, Circulating/pathology , Signal Processing, Computer-Assisted
3.
ACS Biomater Sci Eng ; 5(3): 1553-1560, 2019 Mar 11.
Article in English | MEDLINE | ID: mdl-33405628

ABSTRACT

The development of cell-specific photoacoustic (PA) contrast agents within systems of fluidic flow provides opportunities for the accurate detection of early stage cancer metastasis. Despite the promise of exogenous contrast agents for use in clinical settings, applications are currently limited by both material biocompatibility and target specificity. In this study, folic acid functionalized copper sulfide nanoparticles (FA-CuS NPs) are synthesized to enable ovarian-cancer-specific binding and PA detection in a custom flow system. Folate receptors, known to be overexpressed on the surface of ovarian cancer cells, have remained an ideal candidate for specific targeting through functionalization on nanoparticles and other contrast agents. In combination with copper sulfide nanoparticles' strong absorbance in the near-infrared (NIR), these FA-CuS NPs are an ideal contrast agent capable of being detected by photoacoustic flow cytometry. For the first time, this study shows a potential PA contrast agent to accurately identify ovarian circulating tumor cells in flow.

4.
Sci Rep ; 7(1): 17610, 2017 12 14.
Article in English | MEDLINE | ID: mdl-29242618

ABSTRACT

Recent infectious outbreaks highlight the need for platform technologies that can be quickly deployed to develop therapeutics needed to contain the outbreak. We present a simple concept for rapid development of new antimicrobials. The goal was to produce in as little as one week thousands of doses of an intervention for a new pathogen. We tested the feasibility of a system based on antimicrobial synbodies. The system involves creating an array of 100 peptides that have been selected for broad capability to bind and/or kill viruses and bacteria. The peptides are pre-screened for low cell toxicity prior to large scale synthesis. Any pathogen is then assayed on the chip to find peptides that bind or kill it. Peptides are combined in pairs as synbodies and further screened for activity and toxicity. The lead synbody can be quickly produced in large scale, with completion of the entire process in one week.


Subject(s)
Anti-Infective Agents/pharmacology , Drug Discovery/methods , Protein Array Analysis/methods , Amino Acid Sequence , Anti-Bacterial Agents/pharmacology , Bacteria/metabolism , Disease Outbreaks/prevention & control , Humans , Microbial Sensitivity Tests , Peptides/immunology , Peptides/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...